Additionally, NT‐proBNP is less useful in HFpEF compared with HFrEF because clinical features of HFpEF, such as atrial fibrillation, obesity, and renal impairment significantly impact NT‐proBNP. Here, NPPB is linked to obesity due to melanocortin 4 receptor deficiency.